Literature DB >> 21426301

Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.

Andrew J Shih1, Shannon E Telesco, Sung-Hee Choi, Mark A Lemmon, Ravi Radhakrishnan.   

Abstract

The EGFR (epidermal growth factor receptor)/ErbB/HER (human EGFR) family of kinases contains four homologous receptor tyrosine kinases that are important regulatory elements in key signalling pathways. To elucidate the atomistic mechanisms of dimerization-dependent activation in the ErbB family, we have performed molecular dynamics simulations of the intracellular kinase domains of three members of the ErbB family (those with known kinase activity), namely EGFR, ErbB2 (HER2) and ErbB4 (HER4), in different molecular contexts: monomer against dimer and wild-type against mutant. Using bioinformatics and fluctuation analyses of the molecular dynamics trajectories, we relate sequence similarities to correspondence of specific bond-interaction networks and collective dynamical modes. We find that in the active conformation of the ErbB kinases, key subdomain motions are co-ordinated through conserved hydrophilic interactions: activating bond-networks consisting of hydrogen bonds and salt bridges. The inactive conformations also demonstrate conserved bonding patterns (albeit less extensive) that sequester key residues and disrupt the activating bond network. Both conformational states have distinct hydrophobic advantages through context-specific hydrophobic interactions. We show that the functional (activating) asymmetric kinase dimer interface forces a corresponding change in the hydrophobic and hydrophilic interactions that characterize the inactivating bond network, resulting in motion of the αC-helix through allostery. Several of the clinically identified activating kinase mutations of EGFR act in a similar fashion to disrupt the inactivating bond network. The present molecular dynamics study reveals a fundamental difference in the sequence of events in EGFR activation compared with that described for the Src kinase Hck.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21426301      PMCID: PMC3138537          DOI: 10.1042/BJ20101791

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Structure and regulation of Src family kinases.

Authors:  Titus J Boggon; Michael J Eck
Journal:  Oncogene       Date:  2004-10-18       Impact factor: 9.867

Review 3.  EGF-ERBB signalling: towards the systems level.

Authors:  Ami Citri; Yosef Yarden
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

4.  Src kinase activation: A switched electrostatic network.

Authors:  Elif Ozkirimli; Carol Beth Post
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

5.  An electrostatic network and long-range regulation of Src kinases.

Authors:  Elif Ozkirimli; Shalini S Yadav; W Todd Miller; Carol Beth Post
Journal:  Protein Sci       Date:  2008-08-07       Impact factor: 6.725

6.  Anatomy of a structural pathway for activation of the catalytic domain of Src kinase Hck.

Authors:  Nilesh K Banavali; Benoît Roux
Journal:  Proteins       Date:  2007-06-01

7.  Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation.

Authors:  Ami Citri; Judith Gan; Yaron Mosesson; Gyorgi Vereb; Janos Szollosi; Yosef Yarden
Journal:  EMBO Rep       Date:  2004-12       Impact factor: 8.807

Review 8.  Protein tyrosine kinase structure and function.

Authors:  S R Hubbard; J H Till
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

9.  Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation.

Authors:  Athanasios Papakyriakou; Dionisios Vourloumis; Fotini Tzortzatou-Stathopoulou; Michael Karpusas
Journal:  Proteins       Date:  2009-08-01

10.  Molecular systems biology of ErbB1 signaling: bridging the gap through multiscale modeling and high-performance computing.

Authors:  Andrew J Shih; Jeremy Purvis; Ravi Radhakrishnan
Journal:  Mol Biosyst       Date:  2008-09-12
View more
  14 in total

Review 1.  Structural systems biology and multiscale signaling models.

Authors:  Shannon E Telesco; Ravi Radhakrishnan
Journal:  Ann Biomed Eng       Date:  2012-04-27       Impact factor: 3.934

2.  Exploring the dynamics and interaction of a full ErbB2 receptor and Trastuzumab-Fab antibody in a lipid bilayer model using Martini coarse-grained force field.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martinez-Salazar
Journal:  J Comput Aided Mol Des       Date:  2014-08-17       Impact factor: 3.686

3.  Investigating Molecular Mechanisms of Activation and Mutation of the HER2 Receptor Tyrosine Kinase through Computational Modeling and Simulation.

Authors:  Shannon E Telesco; Andrew Shih; Yingting Liu; Ravi Radhakrishnan
Journal:  Cancer Res J       Date:  2011

4.  Mechanistic Insights into R776H Mediated Activation of Epidermal Growth Factor Receptor Kinase.

Authors:  Zheng Ruan; Natarajan Kannan
Journal:  Biochemistry       Date:  2015-07-06       Impact factor: 3.162

5.  Conformational flexibility of the ErbB2 ectodomain and trastuzumab antibody complex as revealed by molecular dynamics and principal component analysis.

Authors:  Juan Felipe Franco-Gonzalez; Victor L Cruz; Javier Ramos; Javier Martínez-Salazar
Journal:  J Mol Model       Date:  2012-11-17       Impact factor: 1.810

6.  Molecular modeling of ErbB4/HER4 kinase in the context of the HER4 signaling network helps rationalize the effects of clinically identified HER4 somatic mutations on the cell phenotype.

Authors:  Shannon E Telesco; Rajanikanth Vadigepalli; Ravi Radhakrishnan
Journal:  Biotechnol J       Date:  2013-12-04       Impact factor: 4.677

Review 7.  Computational algorithms for in silico profiling of activating mutations in cancer.

Authors:  E Joseph Jordan; Keshav Patil; Krishna Suresh; Jin H Park; Yael P Mosse; Mark A Lemmon; Ravi Radhakrishnan
Journal:  Cell Mol Life Sci       Date:  2019-04-13       Impact factor: 9.261

8.  Computational and Experimental Characterization of Patient Derived Mutations Reveal an Unusual Mode of Regulatory Spine Assembly and Drug Sensitivity in EGFR Kinase.

Authors:  Zheng Ruan; Samiksha Katiyar; Natarajan Kannan
Journal:  Biochemistry       Date:  2016-12-22       Impact factor: 3.162

9.  A multiscale modeling approach to investigate molecular mechanisms of pseudokinase activation and drug resistance in the HER3/ErbB3 receptor tyrosine kinase signaling network.

Authors:  Shannon E Telesco; Andrew J Shih; Fei Jia; Ravi Radhakrishnan
Journal:  Mol Biosyst       Date:  2011-04-20

10.  ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.

Authors:  Scott C Bresler; Daniel A Weiser; Peter J Huwe; Jin H Park; Kateryna Krytska; Hannah Ryles; Marci Laudenslager; Eric F Rappaport; Andrew C Wood; Patrick W McGrady; Michael D Hogarty; Wendy B London; Ravi Radhakrishnan; Mark A Lemmon; Yaël P Mossé
Journal:  Cancer Cell       Date:  2014-11-10       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.